Lorbas , - how right you are , and I will never un
Post# of 148181
and Ibalizumab with 43% efficacy also with some bad side effects , and IV treatment ,
but didn't approve Leronlimab with 81% , with 350 mg , and we the only one without one single severe side effect...
I don't want to be in conspiracy group , as some saying , but then I need to have logical explanation here from FDA....
IMO as always..